Consequently MMP12 cleavage may underlie the increased circulating levels of galectin-3 observed in patients with cardiovascular diseases, particularly given that commercially available ELISAs for galectin-3 do not discriminate between full-length and cleaved forms of galectin-3. The gene discussed is LGALS3; the disease is cardiovascular disorder.